Fishman Jay A LTD Beam Therapeutics Inc. Transaction History

Fishman Jay A LTD

  • $1.01 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024
SELL
$21.22 - $32.66 $10 Million - $15.5 Million
-473,361 Reduced 97.93%
10,000 $234,000
Q2 2024

Jul 31, 2024
BUY
$21.22 - $32.66 $10 Million - $15.5 Million
473,361 Added 4733.61%
483,361 $11.3 Million
Q1 2024

Apr 23, 2024
BUY
$23.46 - $45.07 $234,600 - $450,700
10,000 New
10,000 $330,000

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $1.78B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Fishman Jay A LTD Portfolio

Follow Fishman Jay A LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fishman Jay A LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email